INTEGRATED CORE STRATEGIES (US) LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share
Symbol
ENTA
Shares outstanding
27,767,902 shares
Disclosed Ownership
1,138,484 shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Filing time
13 Nov 2025, 16:29:26 UTC
Date of event
30 Sep 2025
Previous filing
22 Jan 2025
Next filing
20 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 4.1% ownership in Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA) on 30 Sep 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA).
  • Disclosed ownership: 4.1%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 22 Jan 2025.
  • Current filing was accepted on 13 Nov 2025, 16:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 4% 1,112,864 0 1,112,864 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 4.1% 1,138,484 0 1,138,484 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 4.1% 1,138,484 0 1,138,484 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 4.1% 1,138,484 0 1,138,484 /s/ Israel A. Englander Israel A. Englander

Sponsored